Dr Agarwal’s Health [AGARWALEYE] vs Prevest Denpro [PREVEST] Detailed Stock Comparison

Dr Agarwal's Health

NSE

Prevest Denpro

BSE

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Dr Agarwal's Health wins in 6 metrics, Prevest Denpro wins in 11 metrics, with 0 ties. Prevest Denpro appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Dr Agarwal's Health	Prevest Denpro	Better
P/E Ratio (TTM)	358.78	35.41	Prevest Denpro
Price-to-Book Ratio	7.71	6.08	Prevest Denpro
Debt-to-Equity Ratio	49.87	0.00	Prevest Denpro
EV/EBITDA	36.29	22.23	Prevest Denpro
Profit Margin (TTM)	5.66%	28.73%	Prevest Denpro
Operating Margin (TTM)	13.32%	35.36%	Prevest Denpro
EBITDA Margin (TTM)	13.32%	35.36%	Prevest Denpro
Return on Equity	1.14%	17.20%	Prevest Denpro
Return on Assets (TTM)	0.60%	16.13%	Prevest Denpro
Free Cash Flow (TTM)	$394.30M	$128.49M	Dr Agarwal's Health
1-Year Return	13.33%	-4.92%	Dr Agarwal's Health
Price-to-Sales Ratio (TTM)	8.03	9.77	Dr Agarwal's Health
Enterprise Value	$149.02B	$5.81B	Dr Agarwal's Health
EV/Revenue Ratio	8.30	9.22	Dr Agarwal's Health
Gross Profit Margin (TTM)	43.48%	86.70%	Prevest Denpro
Revenue per Share (TTM)	$58	$55	Dr Agarwal's Health
Earnings per Share (Diluted)	$1.27	$15.11	Prevest Denpro

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Dr Agarwal's Health vs Prevest Denpro Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Dr Agarwal's Health	0.09%	4.60%	1.26%	17.04%	13.20%	13.44%
Prevest Denpro	3.32%	3.19%	-2.87%	23.64%	28.42%	-6.24%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Dr Agarwal's Health	13.33%	13.33%	13.33%	13.33%	13.33%	13.33%
Prevest Denpro	-4.92%	38.76%	112.28%	112.28%	112.28%	112.28%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Dr Agarwal's Health (AGARWALEYE): View Full Stock Overview

Prevest Denpro (PREVEST): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Dr Agarwal's Health vs Prevest Denpro

Metric	AGARWALEYE	PREVEST
Market Information
Market Cap i	₹144.06B	₹6.42B
Market Cap Category	Mid cap	Small cap
10 Day Avg. Volume i	305,083	5,240
90 Day Avg. Volume i	256,161	9,927
Last Close	₹455.65	₹562.55
52 Week Range	₹327.00 - ₹494.50	₹393.60 - ₹686.00
% from 52W High	-7.86%	-18.00%
All-Time High	₹494.50 (Jul 30, 2025)	₹686.00 (Jan 13, 2025)
% from All-Time High	-7.86%	-18.00%
Growth Metrics
Quarterly Revenue Growth	0.21%	0.27%
Quarterly Earnings Growth	1.51%	0.20%
Financial Health
Profit Margin (TTM) i	0.06%	0.29%
Operating Margin (TTM) i	0.13%	0.35%
Return on Equity (TTM) i	0.01%	0.17%
Debt to Equity (MRQ) i	49.87	0.00
Cash & Liquidity
Book Value per Share (MRQ)	₹59.09	₹87.96
Cash per Share (MRQ)	₹16.23	N/A
Operating Cash Flow (TTM) i	₹1.47B	₹185.37M
Levered Free Cash Flow (TTM) i	₹219.30M	₹181.55M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Dr Agarwal's Health vs Prevest Denpro

Metric	AGARWALEYE	PREVEST
Price Ratios
P/E Ratio (TTM) i	358.78	35.41
Forward P/E i	81.93	N/A
PEG Ratio i	N/A	N/A
Price to Sales (TTM) i	8.03	9.77
Price to Book (MRQ) i	7.71	6.08
Market Capitalization
Market Capitalization i	₹144.06B	₹6.42B
Enterprise Value i	₹149.02B	₹5.81B
Enterprise Value Metrics
Enterprise to Revenue i	8.30	9.22
Enterprise to EBITDA i	36.29	22.23
Risk & Other Metrics
Beta i	N/A	N/A
Book Value per Share (MRQ) i	₹59.09	₹87.96

Financial Statements Comparison: Dr Agarwal's Health vs Prevest Denpro

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	AGARWALEYE	PREVEST
Revenue/Sales i	₹4.87B	₹184.55M
Cost of Goods Sold i	₹2.75B	₹24.54M
Gross Profit i	₹2.12B	₹160.01M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹649.10M	₹60.76M
EBITDA i	₹1.41B	₹76.23M
Pre-Tax Income i	₹536.00M	₹71.51M
Income Tax i	₹155.40M	₹20.16M
Net Income (Profit) i	₹380.60M	₹51.41M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	AGARWALEYE	PREVEST
Cash & Equivalents i	₹1.04B	₹608.98M
Total Current Assets i	₹7.94B	₹857.16M
Total Current Liabilities i	₹4.78B	₹59.62M
Long-Term Debt i	₹8.08B	₹0
Total Shareholders Equity i	₹19.27B	₹1.06B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹13.40B	₹268.13M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	AGARWALEYE	PREVEST
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	AGARWALEYE	PREVEST
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	305,083	5,240
Average Daily Volume (90 Day) i	256,161	9,927
Shares Outstanding i	315.88M	12.00M
Float Shares i	N/A	2.61M
% Held by Insiders i	0.76%	0.78%
% Held by Institutions i	0.17%	0.00%

Dividend Analysis & Yield Comparison: Dr Agarwal's Health vs Prevest Denpro

Metric	AGARWALEYE	PREVEST
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Dr Agarwal's Health [AGARWALEYE] vs Prevest Denpro [PREVEST] Detailed Stock Comparison